Pro
00.71.31.92.6USD Million20192020202120222023202420252026
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Distribution Channel
| Label | Appetite Suppressants | Combination Drugs | GLP-1 Receptor Agonists | Lipase Inhibitors | Others |
|---|---|---|---|---|---|
| 2019 | 0.0035 USD Million | 0.0416 USD Million | 0.2485 USD Million | 0.0027 USD Million | 0.0023 USD Million |
| 2020 | 0.0043 USD Million | 0.0529 USD Million | 0.3106 USD Million | 0.0033 USD Million | 0.0028 USD Million |
| 2021 | 0.0055 USD Million | 0.0693 USD Million | 0.3994 USD Million | 0.0042 USD Million | 0.0035 USD Million |
| 2022 | 0.0074 USD Million | 0.0969 USD Million | 0.5486 USD Million | 0.0056 USD Million | 0.0047 USD Million |
| 2023 | 0.011 USD Million | 0.1476 USD Million | 0.8208 USD Million | 0.0082 USD Million | 0.0067 USD Million |
| 2024 | 0.0211 USD Million | 0.2929 USD Million | 1.5974 USD Million | 0.0157 USD Million | 0.0117 USD Million |
| 2025 | 0.0247 USD Million | 0.3542 USD Million | 1.9002 USD Million | 0.0182 USD Million | 0.0139 USD Million |
| 2026 | 0.0291 USD Million | 0.431 USD Million | 2.2749 USD Million | 0.0212 USD Million | 0.0165 USD Million |
| 2027 | 0.0344 USD Million | 0.528 USD Million | 2.7414 USD Million | 0.0248 USD Million | 0.0196 USD Million |
| 2028 | 0.0411 USD Million | 0.6512 USD Million | 3.326 USD Million | 0.0293 USD Million | 0.0232 USD Million |
| 2029 | 0.0494 USD Million | 0.8088 USD Million | 4.0633 USD Million | 0.0348 USD Million | 0.0274 USD Million |
| 2030 | 0.0598 USD Million | 1.0119 USD Million | 4.9996 USD Million | 0.0416 USD Million | 0.0321 USD Million |
| 2031 | 0.0729 USD Million | 1.2754 USD Million | 6.1972 USD Million | 0.0501 USD Million | 0.0375 USD Million |
| 2032 | 0.0895 USD Million | 1.6199 USD Million | 7.74 USD Million | 0.0609 USD Million | 0.0433 USD Million |
| 2033 | 0.1108 USD Million | 2.0736 USD Million | 9.7426 USD Million | 0.0745 USD Million | 0.0495 USD Million |
| 2034 | 0.1383 USD Million | 2.6761 USD Million | 12.3619 USD Million | 0.0919 USD Million | 0.0555 USD Million |
| 2035 | 0.174 USD Million | 3.4826 USD Million | 15.8152 USD Million | 0.1144 USD Million | 0.0604 USD Million |
Data Source: Wantstats Repository
Growth Outlook
- The Obesity Drugs Market By Treatment Type portion of the Global Anti market is on a steady long-term growth path. Segment value stands at roughly USD 3 Million in 2026 and is projected to reach USD 20 Million by 2035 — a gain of about 609% over the forecast period, translating to a CAGR in the double digits.
- What the regional split looks like (2026): GLP-1 Receptor Agonists leads, holding roughly 82% of segment value — the single largest regional share. Combination Drugs is the second-largest contributor. Appetite Suppressants, Lipase Inhibitors and Others make up the remainder, in descending order.
- By 2035, GLP-1 Receptor Agonists alone is expected to reach USD 16 Million, with Combination Drugs at USD 3 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowRelated Charts
View AllPro
00.71.42.12.8USD Million20192020202120222023202420252026
Oral
Subcutaneous
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Route Of Administration
Pro
00.71.42.12.8USD Million20192020202120222023202420252026
Centrally Acting Anti-Obesity Drugs
Peripherally Acting Anti-Obesity Drugs
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Mechanism Of Action
Powering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.